LNKCHEMSOLUTIONS

Basic Information

4701 INNOVATION DRIVE
LINCOLN, NE, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 131068186
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics

    Amount: $296,413.00

    DESCRIPTION: The goal of the proposed project is to develop a biocompatible ultrafine particle-based vector system for the intranasal delivery of clozapine for the pharmacological therapy of treatment ...

    STTR Phase I 2012 Department of Health and Human Services
  2. Nanoparticles and Nanocapsules for Glioma Targeting

    Amount: $2,000,001.00

    DESCRIPTION (provided by applicant): Malignant gliomas represent a heterogeneous family of tumors that are poorly responsive to current treatments. A major obstacle to the effective management of thes ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Improved Formulations to Enhance Bio-availability for Antisense Therapeutics

    Amount: $70,000.00

    In general, many biological and chemical agents affect the lungs directly or indirectly, even if the respiratory system is not the primary target organ of a military or terrorist attack. Both in the c ...

    SBIR Phase I 2010 Office for Chemical and Biological Defense Department of Defense
  4. Development of New Hemostatic Dressings

    Amount: $399,994.00

    DESCRIPTION (provided by applicant): A multidisciplinary team of researchers seeks to develop novel and economically feasible implantable hemostatic dressings for severe (e.g. arterial) bleeding. Key ...

    SBIR Phase I 2009 Department of Health and Human Services
  5. Nanoparticles and Nanocapsules for Glioma Targeting

    Amount: $400,001.00

    DESCRIPTION (provided by applicant): LNK Chemsolutions LLC collaborates with researchers from the University of Chicago to develop nanocapsule technology for enhanced delivery to gliomas. Preliminary ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. Nanoengineered Encapsulation of Enzyme Chiral Catalysts and Other Proteins in Their Native State

    Amount: $750,000.00

    The commercial opportunities for products based on delicate biomolecules, such as enzymes and therapeutic proteins, are growing at a strong pace. However, many proteins of great commercial value, inc ...

    SBIR Phase II 2006 Department of Energy
  7. SBIR Phase I: Catalytic Traps for Capture of Gas-Phase Toxic Linear Molecules

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I project will explore the use of a material comprising a fibrous substrate and an inorganic adsorbent/catalytic coating for removal of toxic small ...

    SBIR Phase I 2006 National Science Foundation
  8. STTR Phase I: Nanoengineered Encapsulation of Therapeutics

    Amount: $100,000.00

    This Small Business Technology Transfer (STTR) Phase I project is a feasibility study for the design of true core-shell type nonocapsules for drug delivery. The research will focus on strategies aime ...

    STTR Phase I 2006 National Science Foundation
  9. Micro/Nano-Encapsulation of Partial Oxidation Biocatalysts

    Amount: $99,999.00

    78011S Many industrial liquid-phase catalytic processes that require the use of some kind of active species (e.g. sensors, biosensors, chelating agents, and chemical traps) cannot be ¿heterogeneized ...

    SBIR Phase I 2005 Department of Energy
  10. Submicron Particles and Fibers for Toxicological Studies

    Amount: $376,119.00

    DESCRIPTION (provided by applicant): This Phase I SBIR program is aimed at initiating a business venture dedicated to the manufacturing of nanoparticulates for toxicology research. The rate of nanotec ...

    SBIR Phase I 2005 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government